Munich ’s Temedica adds €25 million in Series B round, now at €42 million

Munich-based medtech startup Temedica has added an additional €25 million to its Series B round, now taking the total to a healthy €42 million. The extension round was led by existing investors MIG Capital as well as an undisclosed Munich-based family office. The new funding is aimed at further…#munichbasedmedtech #temedica #undisclosedmunichbased #munichbased #understanding #insights #temedicaecosystem #mig #additional #healthy
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Funding | Health